October 10, 2016
Onxeo to Present at the 15th Annual BIO Investor Forum in San Francisco
Media
October 04, 2016
Mundipharma and Orexo announce EU regulatory submission for Zubsolv®
October 03, 2016
Strongbridge Biopharma plc Announces Appointment of Jeffrey W. Sherman, M.D., FACP, to Board of Directors
September 30, 2016
Onxeo Raises €12.5 Million through Capital Increase with US and European Investors
September 28, 2016
HealthCap makes 104th investment as Swedish company Oncorena secures SEK 24m financing
September 23, 2016
Safety Review Committee supports dose escalation with Betalutin® in Lymrit 37-01 trial pending safety data from cohort receiving higher pre-dosing
September 21, 2016
NORDIC NANOVECTOR ASA – CHANGES TO THE BOARD OF DIRECTORS AND NOTICE OF EXTRAORDINARY GENERAL MEETING
September 21, 2016
WILSON THERAPEUTICS ANNOUNCES SUPPORT OF THE ANNUAL EVENT BIG WOW TO RAISE AWARENESS OF WILSON DISEASE
September 15, 2016
Nexstim Plc agrees the next steps of the NBT stroke de novo submission with the FDA
September 12, 2016
Onxeo Announces First Outcomes of Livatag® Preclinical Plan